RMTI Valuation

Rockwell Medical Inc

Add to Watchlist

Advanced Chart

1.120

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

RMTI Relative Valuation

RMTI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RMTI is overvalued; if below, it's undervalued.

Historical Valuation

Rockwell Medical Inc (RMTI) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.56 is considered Undervalued compared with the five-year average of 0.20. The fair price of Rockwell Medical Inc (RMTI) is between 4.12 to 5.51 according to relative valuation methord. Compared to the current price of 1.12 USD , Rockwell Medical Inc is Undervalued By 72.81%.

Relative Value

Fair Zone

4.12-5.51

Current Price：1.12

72.81%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.22

P/B

Median3y

2.36

Median5y

2.99

5.59

FCF Yield

Median3y

-47.48

Median5y

-56.84

Competitors Valuation Multiple

The average P/S ratio for RMTI's competitors is 8.34, providing a benchmark for relative valuation. Rockwell Medical Inc Corp (RMTI) exhibits a P/S ratio of 0.56, which is -93.28% above the industry average. Given its robust revenue growth of -16.59%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap